{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:43:28Z","timestamp":1788831808058,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","award":["1124002"],"award-info":[{"award-number":["1124002"]}],"id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","award":["3729227"],"award-info":[{"award-number":["3729227"]}],"id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Auckland Research Development Fund"},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.breast.2025.104521","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T20:02:52Z","timestamp":1750276972000},"page":"104521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The effects of adjuvant endocrine therapy on long-term outcomes from ductal carcinoma in situ: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4409-9516","authenticated-orcid":false,"given":"Qian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Elwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana","family":"Cavadino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyu Sin","family":"Aye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandar","family":"Tin Tin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.breast.2025.104521_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/his.14091","article-title":"The 2019 World health organization classification of tumours of the breast","volume":"77","author":"Tan","year":"2020","journal-title":"Histopathology."},{"issue":"8","key":"10.1016\/j.breast.2025.104521_bib2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1158\/1055-9965.EPI-18-1262","article-title":"Incidence of ductal carcinoma in situ in the United States, 2000-2014","volume":"28","author":"Ryser","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.breast.2025.104521_bib3","article-title":"Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study","volume":"369","author":"Mannu","year":"2020","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.breast.2025.104521_bib4","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.breast.2025.104521_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast cancer, version 4.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Gradishar","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"issue":"22","key":"10.1016\/j.breast.2025.104521_bib6","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1200\/JCO.2006.10.2699","article-title":"Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ","volume":"25","author":"Yen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.breast.2025.104521_bib7","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1245\/s10434-017-5930-3","article-title":"Factors influencing use of hormone therapy for ductal carcinoma in situ: a national cancer database study","volume":"24","author":"Nguyen","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.breast.2025.104521_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3747\/co.25.3795","article-title":"Prescribing practices of endocrine therapy for ductal carcinoma in situ in British Columbia","volume":"25","author":"Chaudhry","year":"2018","journal-title":"Curr Oncol"},{"key":"10.1016\/j.breast.2025.104521_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113244","article-title":"Trends and variation in treatment of early breast cancer in European certified breast centres: an EUSOMA-based analysis","volume":"192","author":"van Walle","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2025.104521_bib10","article-title":"Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ: the COMET randomized clinical trial","author":"Hwang","year":"2024","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.breast.2025.104521_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.breast.2014.06.015","article-title":"Postoperative tamoxifen for ductal carcinoma in situ: cochrane systematic review and meta-analysis","volume":"23","author":"Staley","year":"2014","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12253-018-0553-y","article-title":"Endocrine therapy for ductal carcinoma in situ (DCIS) of the breast with breast conserving surgery (BCS) and radiotherapy (RT): a meta-analysis","volume":"26","author":"Yan","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.breast.2025.104521_bib13","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.breast.2025.104521_bib14","article-title":"How to obtain the confidence interval from a P value","volume":"343","author":"Altman","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.breast.2025.104521_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/jrsm.1301","article-title":"A simple method for combining binomial counts or proportions with hazard ratios for evidence synthesis of time-to-event data","volume":"9","author":"Watkins","year":"2018","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.breast.2025.104521_bib16","series-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2014"},{"key":"10.1016\/j.breast.2025.104521_bib17","series-title":"A language and environment for statistical computing","year":"2024"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.breast.2025.104521_bib19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"10.1016\/j.breast.2025.104521_bib20","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1200\/JCO.22.02900","article-title":"Randomized placebo controlled trial of low-dose tamoxifen to prevent recurrence in breast noninvasive neoplasia: a 10-Year Follow-Up of TAM-01 study. Journal article","volume":"41","author":"Lazzeroni","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41523-024-00622-w","article-title":"Lumpectomy without radiation for ductal carcinoma in situ of the breast: 20-year results from the ECOG-ACRIN E5194 study","volume":"10","author":"Wright","year":"2024","journal-title":"NPJ breast cancer"},{"issue":"2","key":"10.1016\/j.breast.2025.104521_bib22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clbc.2023.11.001","article-title":"Treatments and prognosis of the breast ductal carcinoma in situ","volume":"24","author":"Wang","year":"2024","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41523-024-00689-5","article-title":"Survival outcomes after omission of surgery for ductal carcinoma in situ","volume":"10","author":"Poli","year":"2024","journal-title":"NPJ breast cancer"},{"issue":"10","key":"10.1016\/j.breast.2025.104521_bib24","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3348\/kjr.2024.0268","article-title":"A nomogram using imaging features to predict ipsilateral breast tumor recurrence after breast-conserving surgery for ductal carcinoma in situ","volume":"25","author":"Choi","year":"2024","journal-title":"Korean J Radiol"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijrobp.2022.06.072","article-title":"A novel biosignature identifies patients with DCIS with high risk of local recurrence after breast conserving surgery and radiation therapy","volume":"115","author":"Vicini","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2025.104521_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076022","article-title":"Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study","volume":"383","author":"Schmitz","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.breast.2025.104521_bib27","article-title":"Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: retrospective cohort study","volume":"12e83045","author":"Niu","year":"2023","journal-title":"eLife"},{"issue":"2 Supplement","key":"10.1016\/j.breast.2025.104521_bib28","article-title":"Locoregional control benefit of a tumor bed boost for ductal carcinoma in situ (DCIS)","volume":"117","author":"Dreyfuss","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.breast.2025.104521_bib29","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1016\/j.clbc.2023.08.005","article-title":"Real-world evidence on the use of endocrine therapy for ductal carcinoma in situ in patients treated with breast-conserving surgery followed by postoperative radiation therapy: a Brazilian retrospective cohort study","volume":"23","author":"de Sousa","year":"2023","journal-title":"Clin Breast Cancer"},{"issue":"14","key":"10.1016\/j.breast.2025.104521_bib30","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/cam4.4651","article-title":"Molecular subtypes predict second breast events of ductal carcinoma in situ after breast-conserving surgery","volume":"11","author":"Yang","year":"2022","journal-title":"Cancer Med"},{"issue":"1 January","key":"10.1016\/j.breast.2025.104521_bib31","article-title":"Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ","volume":"17","author":"Tsai","year":"2022","journal-title":"PLoS One"},{"issue":"10350","key":"10.1016\/j.breast.2025.104521_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(22)01246-6","article-title":"Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07\/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study","volume":"400","author":"Chua","year":"2022","journal-title":"Lancet"},{"issue":"32","key":"10.1016\/j.breast.2025.104521_bib33","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1200\/JCO.21.01083","article-title":"Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG Oncology\/RTOG 9804","volume":"39","author":"McCormick","year":"2021","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2025.104521_bib34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10549-021-06278-5","article-title":"Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?","volume":"189","author":"Livingston-Rosanoff","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.breast.2025.104521_bib35","doi-asserted-by":"crossref","first-page":"E1939","DOI":"10.1002\/onco.13938","article-title":"Hormone receptor subtype in ductal carcinoma in situ: prognostic and predictive roles of the progesterone receptor","volume":"26","author":"Hwang","year":"2021","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.breast.2025.104521_bib36","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1245\/s10434-021-09972-2","article-title":"Ductal carcinoma in situ in young women: increasing rates of mastectomy and variability in endocrine therapy use","volume":"28","author":"Byun","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.breast.2025.104521_bib37","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s12094-019-02168-x","article-title":"Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients","volume":"22","author":"Cambra","year":"2020","journal-title":"Clin Transl Oncol : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico"},{"key":"10.1016\/j.breast.2025.104521_bib38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.radonc.2018.07.015","article-title":"A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study)","volume":"131","author":"Meattini","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2025.104521_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.breast.2018.11.004","article-title":"Adjuvant radiation therapy in small ductal carcinoma in situ","volume":"43","author":"Cho","year":"2019","journal-title":"Breast"},{"key":"10.1016\/j.breast.2025.104521_bib40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2018.06.027","article-title":"Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK sloane project","volume":"101","author":"Thompson","year":"2018","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/cncr.30972","article-title":"Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situ","volume":"124","author":"Shurell","year":"2018","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.breast.2025.104521_bib42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.clbc.2018.04.002","article-title":"Prognostic significance of clinicopathologic features in patients with breast ductal carcinoma-in-situ who received breast-conserving surgery","volume":"18","author":"Kuo","year":"2018","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1016\/j.breast.2025.104521_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10549-018-4681-6","article-title":"Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean breast cancer registry database","volume":"169","author":"Hwang","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13014-018-0964-7","article-title":"Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases","volume":"13","author":"Corradini","year":"2018","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.breast.2025.104521_bib45","first-page":"62","article-title":"Does progesterone receptor matter in the risk of recurrence for patients with ductal carcinoma in situ?","volume":"117","author":"Chaudhary","year":"2018","journal-title":"Wis Med J : official publication of the State Medical Society of Wisconsin"},{"issue":"8","key":"10.1016\/j.breast.2025.104521_bib46","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamaoncol.2016.6948","article-title":"Association of radiotherapy boost for ductal carcinoma in situ with local control after whole-breast radiotherapy","volume":"3","author":"Moran","year":"2017","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.breast.2025.104521_bib47","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1245\/s10434-017-5931-2","article-title":"Contralateral breast cancer risk in women with ductal carcinoma in situ: is it high enough to justify bilateral mastectomy?","volume":"24","author":"Miller","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.breast.2025.104521_bib48","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.clbc.2016.10.005","article-title":"Hypofractionation is an acceptable alternative to conventional fractionation in the treatment of postlumpectomy ductal carcinoma in situ with radiotherapy","volume":"17","author":"Isfahanian","year":"2017","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.breast.2025.104521_bib49","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10549-017-4205-9","article-title":"Relationship of breast MRI to recurrence rates in patients undergoing breast-conservation treatment","volume":"163","author":"Hill","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.breast.2025.104521_bib50","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/ijc.30254","article-title":"Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS. Journal article","volume":"139","author":"Guerrieri-Gonzaga","year":"2016","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.breast.2025.104521_bib51","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1245\/s10434-016-5249-5","article-title":"Impact of age on risk of recurrence of ductal carcinoma in situ: Outcomes of 2996 women treated with breast-conserving surgery over 30 years","volume":"23","author":"Cronin","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.breast.2025.104521_bib52","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/annonc\/mdv251","article-title":"Population-based analysis of the impact and generalizability of the NSABP-B24 study on endocrine therapy for patients with ductal carcinoma in situ of the breast","volume":"26","author":"Lo","year":"2015","journal-title":"Ann Oncol : official journal of the European Society for Medical Oncology"},{"issue":"11","key":"10.1016\/j.breast.2025.104521_bib53","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.clon.2014.08.004","article-title":"Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast","volume":"26","author":"Wang","year":"2014","journal-title":"Clin Oncol (Royal College of Radiologists (Great Britain))"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PPO.0000000000000025","article-title":"Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the memorial sloan-kettering cancer center DCIS nomogram","volume":"20","author":"Sweldens","year":"2014","journal-title":"Cancer journal (Sudbury, Mass)"},{"issue":"5","key":"10.1016\/j.breast.2025.104521_bib55","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.amjsurg.2013.03.008","article-title":"The consequence of undertreatment of patients treated with breast conserving therapy for ductal carcinoma in-situ","volume":"206","author":"Lee","year":"2013","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.breast.2025.104521_bib56","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ijrobp.2013.08.026","article-title":"Hypofractionated radiation therapy for breast ductal carcinoma in situ","volume":"87","author":"Hathout","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib57","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/cncr.27707","article-title":"Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast","volume":"119","author":"Bailes","year":"2013","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.breast.2025.104521_bib58","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1200\/JCO.2011.36.4976","article-title":"Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision","volume":"30","author":"Yi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104521_bib59","first-page":"S58","article-title":"Biology, treatment, and outcome in very young and older women with DCIS","volume":"1","author":"Alvarado","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.breast.2025.104521_bib60","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2453","article-title":"Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting","volume":"11","author":"Habel","year":"2009","journal-title":"Breast Cancer Res"},{"issue":"6","key":"10.1016\/j.breast.2025.104521_bib61","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.clon.2006.04.003","article-title":"Wide local excision and radiotherapy for the treatment of ductal carcinoma in situ of the breast: the Hong Kong experience","volume":"18","author":"Yau","year":"2006","journal-title":"Clin Oncol"},{"issue":"8","key":"10.1016\/j.breast.2025.104521_bib62","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.3390\/cancers15082392","article-title":"Analysis of local recurrence risk in ductal carcinoma in situ and external validation of the memorial sloan kettering cancer center nomogram","volume":"15","author":"Oses","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.breast.2025.104521_bib63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5603\/RPOR.a2021.0026","article-title":"The impact of HER2-directed targeted therapy on HER2-positive DCIS of the breast","volume":"26","author":"Lewis","year":"2021","journal-title":"Rep Practical Oncol Radiother"},{"issue":"6","key":"10.1016\/j.breast.2025.104521_bib64","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4174\/astr.2021.101.6.315","article-title":"Analysis of risk factors associated with survival in human epidermal growth factor receptor 2-positive ductal carcinoma in situ using Korean breast cancer society database","volume":"101","author":"Ahn","year":"2021","journal-title":"Annals of surgical treatment and research"},{"issue":"2","key":"10.1016\/j.breast.2025.104521_bib65","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10549-020-06014-5","article-title":"Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes","volume":"186","author":"Halasz","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.breast.2025.104521_bib66","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41379-020-0452-0","article-title":"Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast","volume":"33","author":"Lazzeroni","year":"2020","journal-title":"Mod Pathol : an official journal of the United States and Canadian Academy of Pathology, Inc."},{"issue":"7","key":"10.1016\/j.breast.2025.104521_bib67","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.ejso.2018.04.015","article-title":"Oncoplastic breast surgery for the management of ductal carcinoma in situ (DCIS): is it oncologically safe? A retrospective cohort analysis","volume":"44","author":"De Lorenzi","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2025.104521_bib68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.radonc.2018.12.030","article-title":"Ductal carcinoma in situ and intraoperative partial breast irradiation: who are the best candidates? long-term outcome of a single institution series","volume":"133","author":"Leonardi","year":"2019","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.breast.2025.104521_bib69","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1245\/s10434-015-4740-8","article-title":"Decreasing recurrence rates for ductal carcinoma in situ: analysis of 2996 women treated with breast-conserving surgery over 30 years","volume":"22","author":"Subhedar","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.breast.2025.104521_bib70","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/SLA.0000000000001454","article-title":"Relationship between margin width and recurrence of ductal carcinoma in situ analysis of 2996 women treated with breast conserving surgery for 30 years","volume":"262","author":"Van Zee","year":"2015","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.breast.2025.104521_bib71","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1245\/s10434-013-3424-5","article-title":"Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation","volume":"21","author":"Pilewskie","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"10.1016\/j.breast.2025.104521_bib72","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1200\/JCO.2009.26.8847","article-title":"Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ","volume":"28","author":"Rudloff","year":"2010","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.breast.2025.104521_bib73","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.2010.34.0141","article-title":"Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24","volume":"30","author":"Allred","year":"2012","journal-title":"J Clin Oncol"},{"issue":"41","key":"10.1016\/j.breast.2025.104521_bib74","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"2010","author":"Correa","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10549-018-5048-8","article-title":"Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort","volume":"174","author":"Sprague","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10549-020-05823-y","article-title":"Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients","volume":"184","author":"Crystal","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.breast.2025.104521_bib77","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10549-024-07473-w","article-title":"Outcomes from low-risk ductal carcinoma in situ: a systematic review and meta-analysis","volume":"208","author":"Chen","year":"2024","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.breast.2025.104521_bib78","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamasurg.2015.0876","article-title":"Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study","volume":"150","author":"Sagara","year":"2015","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.breast.2025.104521_bib79","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/annonc\/mdv062","article-title":"Molecular phenotypes of DCIS predict overall and invasive recurrence","volume":"26","author":"Williams","year":"2015","journal-title":"Ann Oncol : official journal of the European Society for Medical Oncology"},{"issue":"9114","key":"10.1016\/j.breast.2025.104521_bib80","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomised trials. Early breast cancer trialists' collaborative group","volume":"351","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib81","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1186\/s12885-023-11291-6","article-title":"Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS trial)","volume":"23","author":"Kuo","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cncr.35009","article-title":"Adherence to hormonal therapy after surgery among older women with ductal carcinoma in situ: implications for breast cancer-related adverse health events","volume":"130","author":"Mitchell","year":"2024","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib83","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s12885-023-11122-8","article-title":"Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review","volume":"23","author":"Eliassen","year":"2023","journal-title":"BMC Cancer"},{"issue":"10021","key":"10.1016\/j.breast.2025.104521_bib84","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(15)01168-X","article-title":"Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial","volume":"387","author":"Margolese","year":"2016","journal-title":"Lancet"},{"issue":"10021","key":"10.1016\/j.breast.2025.104521_bib85","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0140-6736(15)01129-0","article-title":"Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial","volume":"387","author":"Forbes","year":"2016","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.breast.2025.104521_bib86","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.breast.2025.104521_bib87","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1470-2045(14)71171-4","article-title":"Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial","volume":"16","author":"Cuzick","year":"2015","journal-title":"Lancet Oncol"},{"issue":"10218","key":"10.1016\/j.breast.2025.104521_bib88","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(19)32955-1","article-title":"Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial","volume":"395","author":"Cuzick","year":"2020","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.breast.2025.104521_bib89","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N Engl J Med"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625005387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625005387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T03:09:41Z","timestamp":1769656181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977625005387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":89,"alternative-id":["S0960977625005387"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104521","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of adjuvant endocrine therapy on long-term outcomes from ductal carcinoma in situ: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104521"}}